Quantum Biopharma Class B Subordinate Voting Shares
QNTM
11 hedge funds and large institutions have $476K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 4 closing their positions.
1,400% more call options, than puts
Call options by funds: $15K | Put options by funds: $1K
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
6% more capital invested
Capital invested by funds: $449K → $476K (+$26.4K)
0.01% more ownership
Funds ownership: 0.02% → 0.03% (+0.01%)
21% less funds holding
Funds holding: 14 → 11 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$131K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$13.3K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$9.75K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.82K |
| 5 |
Renaissance Technologies
New York
|
+$5.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
-$12.5K |
| 2 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
-$9.59K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$2.08K |
| 4 |
FWM
Focused Wealth Management
Newburgh,
New York
|
-$1.02K |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
-$110 |
QNTM Hedge Fund Activity: Q1 2024 in Review
11 of the 6,945 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q1 2024, worth a combined $476K — up 5.9% from $449K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of QNTM and 1 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 5 added.
The largest buyer was AdvisorShares Investments, adding an estimated $131K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $12.5K sold.
- 11 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q1 2024, down from 14 in Q4 2023.
- Funds reported $476K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q1 2024, up 5.9% quarter-over-quarter.
- 1 fund opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q1 2024 and 4 closed out, a net change of -3 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q1 2024 was AdvisorShares Investments, an estimated $131K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q1 2024 was Two Sigma Securities, an estimated $12.5K sold.
Based on aggregated 13F filings for Q1 2024.